Your browser doesn't support javascript.
loading
Targeting GRK2 and GRK5 for treating chronic degenerative diseases: Advances and future perspectives.
Zhang, Ya; Zhang, Jifa; Wang, Jiaxing; Chen, Hao; Ouyang, Liang; Wang, Yuxi.
Affiliation
  • Zhang Y; Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Joint Research Institution of Altitude Health, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610
  • Zhang J; Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Joint Research Institution of Altitude Health, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610
  • Wang J; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, 38163, Tennessee, United States.
  • Chen H; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, 38163, Tennessee, United States.
  • Ouyang L; Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Joint Research Institution of Altitude Health, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610
  • Wang Y; Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Joint Research Institution of Altitude Health, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610
Eur J Med Chem ; 243: 114668, 2022 Dec 05.
Article in En | MEDLINE | ID: mdl-36055000

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Neurodegenerative Diseases / Diabetes Mellitus, Type 2 Limits: Humans Language: En Journal: Eur J Med Chem Year: 2022 Document type: Article Country of publication: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Neurodegenerative Diseases / Diabetes Mellitus, Type 2 Limits: Humans Language: En Journal: Eur J Med Chem Year: 2022 Document type: Article Country of publication: France